Article info

Download PDFPDF

Response to: ‘“MAINRITSAN2-the future”, with some doubts!’ by Chattopadhyay et al
Free

Authors

  • Pierre Charles Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris, France Department of Internal Medicine, Institut Mutualiste Montsouris, Paris, France PubMed articlesGoogle scholar articles
  • Loic Guillevin Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Loic Guillevin, Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris 75014, France; loic.guillevin{at}aphp.fr
View Full Text

Citation

Charles P, Guillevin L
Response to: ‘“MAINRITSAN2-the future”, with some doubts!’ by Chattopadhyay et al

Publication history

  • Received October 12, 2018
  • Accepted October 13, 2018
  • First published October 26, 2018.
Online issue publication 
November 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.